Lupin News: Read Latest News & Live Updates on Lupin, Photos, Videos at CNBCTV18.com

homeLupin News

Lupin NEWS

All

market | Jun 14, 2024 12:59 PM IST
USFDA concludes inspection at Lupin’s Nagpur facility with zero observations
market | May 23, 2024 11:21 AM IST
Lupin shares fall 7% after second largest US contributor drug faces more competition
business | May 19, 2024 10:17 AM IST
Lupin's Somerset facility gets Form-483 with six observations after US FDA inspection
market | May 14, 2024 1:08 PM IST
Pharma analyst names preferred picks in the sector
market | May 7, 2024 3:33 PM IST
Lupin shares fall over 6%, pharma major expresses optimism regarding future growth, product launches
market | May 6, 2024 9:47 PM IST
Lupin Q4 Results | Net profit jumps 52% to ₹359 crore, declares dividend of ₹8
business | May 6, 2024 6:57 PM IST
Pharma major Lupin receives US FDA approval for generic eye solution
market | Apr 23, 2024 11:41 PM IST
USFDA issues inspection report for Lupin's Aurangabad manufacturing facility
market | Apr 21, 2024 5:35 PM IST
Lupin gets USFDA nod to launch generic tablet to treat overactive bladder
business | Apr 15, 2024 1:38 PM IST
Lupin forecasts $200-210 million quarterly sales for US operations this year
market | Apr 12, 2024 5:05 PM IST
Lupin's Gujarat facility successfully clears USFDA inspection with no observations; stock surges
market | Apr 12, 2024 1:53 PM IST
Pharma Q4FY24 earnings preview | Robust US performance expected to drive revenue growth
healthcare | Apr 9, 2024 6:55 PM IST
Lupin launches first generic version of Oracea skin treatment capsules in US
market | Mar 22, 2024 9:10 PM IST
Lupin to sell trade generics business in India to Lupin Life Sciences for ₹100-120 crore
business | Mar 15, 2024 6:27 PM IST
US FDA raises a concern after Lupin's Aurangabad unit inspection

Lupin NEWS

USFDA concludes inspection at Lupin’s Nagpur facility with zero observations

Lupin shares fall 7% after second largest US contributor drug faces more competition

Lupin's Somerset facility gets Form-483 with six observations after US FDA inspection

Pharma analyst names preferred picks in the sector

Lupin shares fall over 6%, pharma major expresses optimism regarding future growth, product launches

Lupin Q4 Results | Net profit jumps 52% to ₹359 crore, declares dividend of ₹8

Pharma major Lupin receives US FDA approval for generic eye solution

USFDA issues inspection report for Lupin's Aurangabad manufacturing facility

Lupin gets USFDA nod to launch generic tablet to treat overactive bladder

Lupin forecasts $200-210 million quarterly sales for US operations this year

Lupin's Gujarat facility successfully clears USFDA inspection with no observations; stock surges

Pharma Q4FY24 earnings preview | Robust US performance expected to drive revenue growth

Lupin launches first generic version of Oracea skin treatment capsules in US

Lupin to sell trade generics business in India to Lupin Life Sciences for ₹100-120 crore

US FDA raises a concern after Lupin's Aurangabad unit inspection